Diagnostic Biomarkers Global Market Report 2025

Description

A diagnostic biomarker is a biological indicator that aids in identifying a disease, distinguishing it from other conditions. This can include various types of findings, such as laboratory test results, radiological imaging, genetic markers, and physiological changes. Additionally, diagnostic biomarkers can offer insights into disease progression and the effectiveness of treatments.

The primary product types in diagnostic biomarkers include safety biomarkers, efficacy biomarkers, and validation biomarkers. Safety biomarkers are measurable indicators used to evaluate the potential risk of toxicity or adverse effects linked to medical treatments or environmental exposures. They help determine the safety of a therapy by monitoring biological responses that may signal harm. These biomarkers are applied in fields such as oncology, metabolic diseases, and neurological disorders, serving end users such as hospitals, cancer research institutes, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diagnostic biomarkers market research report is one of a series of new reports from The Business Research Company that provides diagnostic biomarkers market statistics, including diagnostic biomarkers industry global market size, regional shares, competitors with a diagnostic biomarkers market share, detailed diagnostic biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic biomarkers industry. This diagnostic biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic biomarkers market size has grown rapidly in recent years. It will grow from $65.25 billion in 2024 to $75.46 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, advancements in omics technologies, increasing demand for personalized medicine, growing awareness of early disease detection, and a surge in non-invasive diagnostic methods.

The diagnostic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $135.36 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to growing adoption of liquid biopsy techniques, increasing investment in biomarker research, rising focus on precision medicine, and expanding applications in neurodegenerative diseases. Major trends in the forecast period include the advancements in artificial intelligence and machine learning, the integration of multi-omics approaches, the development of point-of-care diagnostic tools, the shift towards digital biomarkers, the growing use of wearable health monitoring devices, and the increasing emphasis on biomarker validation and standardization.

The forecast of 15.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. precision medicine by inflating prices of troponin assays and circulating tumor DNA tests developed in Belgium and Singapore, resulting in delayed diagnoses and higher laboratory testing expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is driving the expansion of the diagnostic biomarkers market. Various factors, including an aging population, lifestyle changes, environmental exposures, and advancements in diagnostic technology, contribute to the rising prevalence of cancer. Diagnostic biomarkers play a vital role in cancer detection by enabling early identification, accurate diagnosis, and personalized treatment approaches, ultimately improving patient outcomes. For example, in January 2024, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported that the number of cancer cases had risen to 2,001,140 from 1,958,310 in 2023, marking a 2.19% increase. This growing prevalence of cancer continues to fuel the demand for diagnostic biomarkers.

Leading companies in the diagnostic biomarkers market are prioritizing the development of non-invasive testing methods, such as blood-based biomarker tests, to improve patient comfort and accessibility while facilitating personalized treatment approaches. A blood-based biomarker test is a diagnostic tool that examines specific biological markers in the blood to detect or monitor diseases, including Alzheimer's, in a minimally invasive manner. For instance, in July 2023, Quanterix Corporation, a US-based life sciences company, introduced LucentAD, a blood-based biomarker test designed to assist healthcare professionals in diagnosing Alzheimer's disease (AD) in patients with early cognitive symptoms. The test measures plasma levels of phosphorylated tau protein at the 181 residue (p-Tau 181), a biomarker linked to amyloid pathology in the brain, a key indicator of AD. By offering a less invasive and more accessible alternative to traditional diagnostic methods such as cerebrospinal fluid analysis or amyloid positron emission tomography, LucentAD aims to streamline the assessment process for suspected Alzheimer's patients.

In September 2024, Trinity Biotech, an Ireland-based clinical diagnostics company, acquired Metabolomics Diagnostics for approximately $1.3 million. This acquisition enhances Trinity Biotech's capabilities by integrating a strategically significant mass spectrometry platform with machine learning-driven bioinformatics. Metabolomics Diagnostics, also based in Ireland, specializes in developing novel biomarker-based diagnostic solutions for complex diseases.

Major players in the diagnostic biomarkers market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS.

North America was the largest region in the diagnostic biomarkers market in 2024. The regions covered in diagnostic biomarkers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diagnostic biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic biomarkers market consists of revenues earned by entities by providing services such as biomarker assay development and validation, biomarker-based diagnostic testing services, clinical trial support services, and data management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic biomarkers market also includes sales of biomarker assays, liquid biopsy kits, digital biomarkers, and genetic testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers
2) By Application: Oncology; Metabolic Disease; Neurological Disease
3) By End User: Hospitals; Cancer Research Institutes; Diagnostic Labs
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers; Organ-Specific Safety Biomarkers; Drug-Induced Injury Biomarkers
2) By Efficacy Biomarkers: Predictive Biomarkers; Prognostic Biomarkers; Pharmacodynamic Biomarkers
3) By Validation Biomarkers: Genomic Biomarkers; Proteomic Biomarkers; Metabolomic Biomarkers
Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; PerkinElmer Inc.; Siemens Healthineers AG; Merck KGaA; Agilent Technologies Inc.; Charles River Laboratories International Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; Qiagen N.V.; Myriad Genetics Inc.; Meso Scale Diagnostics LLC; EKF Diagnostics Holdings Plc; Sino Biological Inc.; Enzo Biochem Inc.; Biomarker Technologies Inc.; Cisbio Bioassays; Signosis Inc.; Epigenomics AG; LifeSign LLC; Banyan Biomarkers Inc.; Biosims Technologies SAS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34037u

1. Executive Summary

2. Diagnostic Biomarkers Market Characteristics

3. Diagnostic Biomarkers Market Trends And Strategies

4. Diagnostic Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diagnostic Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Diagnostic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Diagnostic Biomarkers Market Growth Rate Analysis
5.4. Global Diagnostic Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Diagnostic Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Diagnostic Biomarkers Total Addressable Market (TAM)

6. Diagnostic Biomarkers Market Segmentation

6.1. Global Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
6.2. Global Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Metabolic Disease
Neurological Disease
6.3. Global Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Research Institutes
Diagnostic Labs
6.4. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Toxicity Biomarkers
Organ-Specific Safety Biomarkers
Drug-Induced Injury Biomarkers
6.5. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Efficacy Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Biomarkers
Prognostic Biomarkers
Pharmacodynamic Biomarkers
6.6. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Validation Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Biomarkers
Proteomic Biomarkers
Metabolomic Biomarkers

7. Diagnostic Biomarkers Market Regional And Country Analysis

7.1. Global Diagnostic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Diagnostic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostic Biomarkers Market

8.1. Asia-Pacific Diagnostic Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostic Biomarkers Market

9.1. China Diagnostic Biomarkers Market Overview
9.2. China Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostic Biomarkers Market

10.1. India Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostic Biomarkers Market

11.1. Japan Diagnostic Biomarkers Market Overview
11.2. Japan Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostic Biomarkers Market

12.1. Australia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostic Biomarkers Market

13.1. Indonesia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostic Biomarkers Market

14.1. South Korea Diagnostic Biomarkers Market Overview
14.2. South Korea Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostic Biomarkers Market

15.1. Western Europe Diagnostic Biomarkers Market Overview
15.2. Western Europe Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostic Biomarkers Market

16.1. UK Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostic Biomarkers Market

17.1. Germany Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostic Biomarkers Market

18.1. France Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostic Biomarkers Market

19.1. Italy Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostic Biomarkers Market

20.1. Spain Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostic Biomarkers Market

21.1. Eastern Europe Diagnostic Biomarkers Market Overview
21.2. Eastern Europe Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostic Biomarkers Market

22.1. Russia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostic Biomarkers Market

23.1. North America Diagnostic Biomarkers Market Overview
23.2. North America Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostic Biomarkers Market

24.1. USA Diagnostic Biomarkers Market Overview
24.2. USA Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostic Biomarkers Market

25.1. Canada Diagnostic Biomarkers Market Overview
25.2. Canada Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostic Biomarkers Market

26.1. South America Diagnostic Biomarkers Market Overview
26.2. South America Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostic Biomarkers Market

27.1. Brazil Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostic Biomarkers Market

28.1. Middle East Diagnostic Biomarkers Market Overview
28.2. Middle East Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostic Biomarkers Market

29.1. Africa Diagnostic Biomarkers Market Overview
29.2. Africa Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostic Biomarkers Market Competitive Landscape And Company Profiles

30.1. Diagnostic Biomarkers Market Competitive Landscape
30.2. Diagnostic Biomarkers Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostic Biomarkers Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG
31.2. Merck KGaA
31.3. Agilent Technologies Inc.
31.4. Charles River Laboratories International Inc.
31.5. Bio-Rad Laboratories Inc.
31.6. Bruker Corporation
31.7. Qiagen N.V.
31.8. Myriad Genetics Inc.
31.9. Meso Scale Diagnostics LLC
31.10. EKF Diagnostics Holdings Plc
31.11. Sino Biological Inc.
31.12. Enzo Biochem Inc.
31.13. Biomarker Technologies Inc.
31.14. Cisbio Bioassays
31.15. Signosis Inc.

32. Global Diagnostic Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Biomarkers Market

34. Recent Developments In The Diagnostic Biomarkers Market

35. Diagnostic Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Diagnostic Biomarkers Market In 2029 - Countries Offering Most New Opportunities
35.2 Diagnostic Biomarkers Market In 2029 - Segments Offering Most New Opportunities
35.3 Diagnostic Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer